Correction to: cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes - Poll - MDSpire

Correction to: cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes

  • By

  • Shailen G. Sampath

  • Anthony J. Tang

  • Alan X. Chen

  • Ashwin Viswanathan

  • Chiemela Izima

  • Alex H. Manriquez

  • Nicholas B. Dadario

  • Nathan Winans

  • Misha Amini

  • Nathaniel Rolfe

  • Arjun R. Adapa

  • Michael G. Argenziano

  • Colin P. Sperring

  • Justin A. Neira

  • Liang Lei

  • Peter Canoll

  • Jeffrey N. Bruce

  • June 25, 2026

  • 0 min

Share

Original Source(s)

Correction to: cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes

  • by Shailen G. Sampath, Anthony J. Tang, Alan X. Chen, Ashwin Viswanathan, Chiemela Izima, Alex H. Manriquez, Nicholas B. Dadario, Nathan Winans, Misha Amini, Nathaniel Rolfe, Arjun R. Adapa, Michael G. Argenziano, Colin P. Sperring, Justin A. Neira, Liang Lei, Peter Canoll, Jeffrey N. Bruce

  • June 25, 2026

Related Content

Combined immunohistochemistry and FISH testing for diagnosing metaplastic thymoma: a case report of misdiagnosis as pulmonary mucinous epidermoid carcinoma

Attitudes and dilemmas facing fertility preservation decision-making by oncology patients from the perspective of healthcare professionals: a qualitative study

Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study